Legacy Financial Strategies’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.35M | Sell |
5,382
-412
| -7% | -$88.6K | 0.21% | 56 |
|
|
2026
Q1 | $1.26M | Sell |
5,794
-103
| -2% | -$22.8K | 0.23% | 53 |
|
|
2025
Q4 | $1.35M | Sell |
5,897
-462
| -7% | -$105K | 0.24% | 54 |
|
|
2025
Q3 | $1.47M | Sell |
6,359
-12,664
| -67% | -$2.58M | 0.27% | 53 |
|
|
2025
Q2 | $3.53M | Sell |
19,023
-90
| -0.5% | -$16.7K | 0.69% | 26 |
|
|
2025
Q1 | $4M | Buy |
19,113
+482
| +3% | +$93.7K | 0.87% | 19 |
|
|
2024
Q4 | $3.34M | Buy |
18,631
+80
| +0.4% | +$14.7K | 0.72% | 24 |
|
|
2024
Q3 | $3.66M | Buy |
18,551
+67
| +0.4% | +$12.5K | 0.81% | 24 |
|
|
2024
Q2 | $3.03M | Buy |
18,484
+1,756
| +10% | +$291K | 0.73% | 28 |
|
|
2024
Q1 | $3.05M | Buy |
16,728
+620
| +4% | +$107K | 0.79% | 25 |
|
|
2023
Q4 | $2.5M | Buy |
16,108
+44
| +0.3% | +$6.42K | 0.71% | 32 |
|
|
2023
Q3 | $2.28M | Buy |
16,064
+597
| +4% | +$87.6K | 0.73% | 33 |
|
|
2023
Q2 | $2.08M | Buy |
15,467
+1,497
| +11% | +$220K | 0.7% | 37 |
|
|
2023
Q1 | $2.23M | Buy |
13,970
+868
| +7% | +$133K | 0.83% | 23 |
|
|
2022
Q4 | $2.12M | Buy |
13,102
+882
| +7% | +$135K | 0.88% | 21 |
|
|
2022
Q3 | $1.64M | Sell |
12,220
-1,631
| -12% | -$234K | 0.76% | 28 |
|
|
2022
Q2 | $2.12M | Buy |
13,851
+506
| +4% | +$77.3K | 1.05% | 14 |
|
|
2022
Q1 | $2.16M | Sell |
13,345
-110
| -0.8% | -$16K | 0.92% | 16 |
|
|
2021
Q4 | $1.82M | Buy |
13,455
+420
| +3% | +$49.6K | 0.79% | 21 |
|
|
2021
Q3 | $1.41M | Buy |
13,035
+888
| +7% | +$101K | 0.66% | 32 |
|
|
2021
Q2 | $1.37M | Buy |
12,147
+716
| +6% | +$80.6K | 0.66% | 33 |
|
|
2021
Q1 | $1.24M | Buy |
11,431
+542
| +5% | +$58K | 0.65% | 31 |
|
|
2020
Q4 | $1.17M | Buy |
10,889
+246
| +2% | +$23.6K | 0.6% | 27 |
|
|
2020
Q3 | $932K | Buy |
10,643
+217
| +2% | +$20.4K | 0.54% | 34 |
|
|
2020
Q2 | $1.02M | Buy |
10,426
+286
| +3% | +$25.2K | 0.79% | 18 |
|
|
2020
Q1 | $773K | Buy |
10,140
+960
| +10% | +$81.8K | 0.73% | 19 |
|
|
2019
Q4 | $813K | Buy |
9,180
+898
| +11% | +$74.6K | 0.66% | 32 |
|
|
2019
Q3 | $649K | Buy |
8,282
+947
| +13% | +$64.9K | 0.58% | 35 |
|
|
2019
Q2 | $523K | Buy |
7,335
+535
| +8% | +$42.1K | 0.49% | 40 |
|
|
2019
Q1 | $548K | Buy |
6,800
+588
| +9% | +$48.1K | 0.47% | 38 |
|
|
2018
Q4 | $573K | Buy |
6,212
+289
| +5% | +$25.4K | 0.57% | 22 |
|
|
2018
Q3 | $522K | Buy |
5,923
+125
| +2% | +$11.9K | 0.53% | 29 |
|
|
2018
Q2 | $537K | Buy |
5,798
+158
| +3% | +$15.4K | 0.48% | 33 |
|
|
2018
Q1 | $534K | Sell |
5,640
-53
| -0.9% | -$5.82K | 0.52% | 30 |
|
|
2017
Q4 | $551K | Buy |
+5,693
| New | +$537K | 0.59% | 30 |
|
Other funds holding ABBV
Legacy Financial Strategies's ABBV Position: Q2 2026 in Review
Legacy Financial Strategies reduced its AbbVie (ABBV) stake by 7.1% in Q2 2026, selling an estimated $88.6K and leaving 5,382 shares worth $1.35M. The position accounts for 0.21% of the portfolio, ranked #56.
Legacy Financial Strategies first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. The position peaked at $4M in Q1 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Legacy Financial Strategies held 5,382 shares of AbbVie worth $1.35M as of Q2 2026.
- Legacy Financial Strategies sold 412 AbbVie shares in Q2 2026, an estimated $88.6K.
- AbbVie made up 0.21% of Legacy Financial Strategies's portfolio in Q2 2026, its #56 holding.
- Legacy Financial Strategies first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- Legacy Financial Strategies's AbbVie position peaked at $4M in Q1 2025.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Legacy Financial Strategies's 13F filing for Q2 2026, filed 21 Jul 2026.